Advertisement
Research Article| Volume 52, ISSUE 5, P632-639, May 2017

Association of Bacterial Vaginosis With Chlamydia and Gonorrhea Among Women in the U.S. Army

Open AccessPublished:November 02, 2016DOI:https://doi.org/10.1016/j.amepre.2016.09.016

      Introduction

      Bacterial vaginosis (BV) is a common vaginal condition in women of reproductive age, which has been associated with Chlamydia trachomatis and Neisseria gonorrhoeae among commercial sex workers and women attending sexually transmitted infection clinics. Pathogen-specific associations between BV and other sexually transmitted infections among U.S. military women have not been investigated.

      Methods

      A population-based, nested case-control study was conducted of all incident chlamydia and gonorrhea cases reported to the Defense Medical Surveillance System during 2006−2012. Using a density sampling approach, for each chlamydia or gonorrhea case, 10 age-matched (±1 year) controls were randomly selected from those women who were never diagnosed with these infections. Incidence rate ratios were estimated using conditional logistic regression. Statistical analysis was carried out in December 2015.

      Results

      A total of 37,149 chlamydia cases and 4,987 gonorrhea cases were identified during the study period. Antecedent BV was associated with an increased risk of subsequent chlamydia (adjusted incidence rate ratio=1.51; 95% CI=1.47, 1.55) and gonorrhea (adjusted incidence rate ratio=2.42; 95% CI=2.27, 2.57) infections. For every one additional episode of BV, the risk of acquiring chlamydia and gonorrhea infections increased by 13% and 26%, respectively. A monotonic dose−response relationship was also noted between antecedent BV and subsequent chlamydia and gonorrhea infection. In addition, an effect modification on the additive scale was found between BV and African-American race for gonorrhea, but not for chlamydia.

      Conclusions

      Among U.S. Army women, antecedent BV is associated with an increased risk of subsequent chlamydia and gonorrhea infection.

      Introduction

      Bacterial vaginosis (BV) is a common vaginal condition characterized by gray/white, thin, and malodorous discharge.
      • Koumans E.H.
      • Sternberg M.
      • Bruce C.
      • et al.
      The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.
      BV is associated with the replacement of normal vaginal lactobacilli by an overgrowth of vaginal anaerobes or Gram-negative bacteria (e.g., Gardnerella vaginalis), which causes an imbalance in the vaginal microflora with a resulting discharge. The BV prevalence varies substantially between countries worldwide.
      • Kenyon C.
      • Colebunders R.
      • Crucitti T.
      The global epidemiology of bacterial vaginosis: a systematic review.
      In the U.S., BV is more frequently reported among African-American and Hispanic women than white women.
      • Koumans E.H.
      • Markowitz L.E.
      • Hogan V.
      CDC BV Working Group
      Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.
      New or multiple male sexual partners have been associated with BV.
      • Fethers K.A.
      • Fairley C.K.
      • Hocking J.S.
      • Gurrin L.C.
      • Bradshaw C.S.
      Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.
      Lower age at first intercourse, past pregnancy, commercial sex work, and vaginal douching are also linked to BV.
      • Yen S.
      • Shafer M.A.
      • Moncada J.
      • et al.
      Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military.
      • Smart S.
      • Singal A.
      • Mindel A.
      Social and sexual risk factors for bacterial vaginosis.
      • Verstraelen H.
      • Verhelst R.
      • Vaneechoutte M.
      • Temmerman M.
      The epidemiology of bacterial vaginosis in relation to sexual behaviour.
      • Fethers K.A.
      • Fairley C.K.
      • Morton A.
      • et al.
      Early sexual experiences and risk factors for bacterial vaginosis.
      Since the work of Leopold
      • Leopold S.
      Heretofore undescribed organism isolated from the genitourinary system.
      and Gardner and Dukes in the 1950s,
      • Gardner H.L.
      • Dukes C.D.
      Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis.
      the etiologic agent of BV has not been established, and there is debate on whether BV constitutes a sexually transmitted infection (STI).
      • Turovskiy Y.
      • Noll K.S.
      • Chikindas M.L.
      The aetiology of bacterial vaginosis.
      However, it is also possible that BV is a sexually enhanced disease.
      • Smart S.
      • Singal A.
      • Mindel A.
      Social and sexual risk factors for bacterial vaginosis.
      Data indicate that BV is a risk factor for the acquisition of pathogens such as HIV, herpes simplex virus Type 2, human papillomavirus, Chlamydia trachomatis, and Neisseria gonorrhoeae.
      • Leppäluoto P.A.
      Autopsy of bacterial vaginosis: a physiological entity rather than a contagious disease.
      • Mirmonsef P.
      • Krass L.
      • Landay A.
      • Spear G.T.
      The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.
      • Nagot N.
      • Quedraogo A.
      • Defer M.C.
      • et al.
      Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies.
      • Brotman R.M.
      • Shardell M.D.
      • Gajer P.
      • et al.
      Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.
      • Wiesenfeld H.C.
      • Hillier S.L.
      • Krohn M.A.
      • Landers D.V.
      • Sweet R.L.
      Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.
      • Gallo M.F.
      • Macaluso M.
      • Warner L.
      • et al.
      Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links.
      For example, one cohort study conducted among non-pregnant women found that those with BV had a 1.8- and 1.9-fold increased risk for gonorrhea and chlamydia, respectively.
      • Brotman R.M.
      • Klebanoff M.A.
      • Nansel T.R.
      • et al.
      Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.
      A secondary data analysis of the Project Protect clinical trial indicated that women with a high BV severity had a 2.7-fold increased risk of acquiring an STI.
      • Allsworth J.E.
      • Peipert J.F.
      Severity of bacterial vaginosis and the risk of sexually transmitted infection.
      According to the Armed Forces Health Surveillance Center, from 2000 through 2012, a total of 87,462 chlamydia and 11,403 gonorrhea cases were reported among military women.
      Armed Forces Health Surveillance Center
      Sexually transmitted infections, active component, U.S. Armed Forces, 2000−2012.
      Chlamydia and gonorrhea rates are higher in military than civilian women. This difference may be due to the high prevalence of risky sexual practices among the predominantly younger military women. However, it might also be the result of a screening effect, as women undergo routine annual screening for STIs.
      The relationship between BV and STIs has not been examined among military women. Thus, this study sought to determine whether antecedent BV was associated with subsequent chlamydia or gonorrhea infection, with special attention paid to Hispanic women, a minority group not previously evaluated. This study also analyzed the role of the number of episodes of BV on STI risk, as a dose−response relationship has not previously been studied. The identification of BV as risk factor for the transmission of these infections has potential implications for prevention efforts in the U.S. military.

      Methods

      Data Sample

      Study data were obtained from the Defense Medical Surveillance System (DMSS); details about this surveillance system have been published elsewhere.
      • Rubertone M.V.
      • Brundage J.F.
      The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.
      Briefly, DMSS is the central repository of medical surveillance data for the U.S. Armed Forces. This relational database contains information on personnel demographics, reportable diseases, deployments, and medical data for all active-duty personnel throughout their careers. DMSS data have previously been used to study HIV and herpes simplex virus Type 2 infections among U.S. military personnel.
      • Bautista C.T.
      • Sateren W.B.
      • Sanchez J.L.
      • et al.
      HIV incidence trends among white and African-American active duty United States Army personnel (1986−2003).
      • Bautista C.T.
      • Singer D.E.
      • O’Connell R.J.
      • et al.
      Herpes simplex virus type 2 and HIV infection among U.S. military personnel: implications for health prevention programmes.
      In this population-based, nested case-control study, all active duty women in the U.S. Army with a first-time diagnosis of chlamydia or gonorrhea, in either the first or second diagnostic position of an outpatient or inpatient, physician-based, diagnostic encounter reported between January 1, 2006 and December 31, 2012, were selected. For case findings, the ICD-9 was applied. For chlamydia cases, the set ICD-9 codes were 099.41 or 099.5, and for gonorrhea cases, the set ICD-9 codes were 098.0x, 098.1x, 098.4x, or 098.8x. Using a density sampling approach,
      • Richardson D.
      An incidence density sampling program for nested case-control analyses.
      a random sample of ten controls composed of women without a chlamydia or gonorrhea diagnosis at the time of diagnosis for the case were matched to each case on age (±1 year). Ten controls per case were chosen to increase the statistical precision of the estimates.
      A BV diagnosis was based on the ICD-9-CM code 616.10 (vaginitis and vulvovaginitis, unspecified) in either the first or the second diagnostic position of an outpatient or inpatient encounter medical record from DMSS, prior to the diagnosis date of chlamydia or gonorrhea. Because recurrent BV episodes are frequent and there is no accepted definition of recurrence,
      • Eschenbach D.A.
      Bacterial vaginosis: resistance, recurrence, and/or reinfection?.
      an episode of recurrent BV was defined as one where a subsequent diagnosis took place ≥30 days from the previously diagnosed BV episode. This criterion was based on the recommendations given by the Centers for Disease Control and Prevention BV Working Group meta-analysis and synthesis report.
      • Koumans E.H.
      • Markowitz L.E.
      • Hogan V.
      CDC BV Working Group
      Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.

      Measures

      Demographic variables, including race, education, marital status, region of birth, rank, and years in service, were extracted from DMSS. These were defined as race/ethnicity (white, African American, Hispanic, and other), education (no high school, high school, and some college or higher), marital status (single, married, and other), rank (lower enlisted [E1−E4], higher enlisted E5−E9], and officers), and years of service (≤1, 2−3, and ≥4). Geographic region or residence (birth) was classified into four regions (West, Midwest, Northeast, and South).

      Statistical Analysis

      The prevalence of BV among cases and controls was compared using the Cochran−Mantel−Haenszel test. To analyze individual matched case-control data, conditional logistic regression was used to estimate the incidence rate ratios with 95% CIs to determine the association between BV and chlamydia and gonorrhea infection. Separate regression models were performed for each variable category. In addition to analyzing BV as a binary variable, BV was treated as a categorical variable to conduct a dose−response relationship analysis. An effect modification analysis on the additive scale was conducted to determine whether the effect of BV on chlamydia or gonorrhea infection differed by race/ethnicity. For analysis, the synergy and the relative excess risk due to interaction [RERI] measures were calculated. Synergy equal to one and RERI equal to zero indicate there is no departure from additivity.
      All p-values were two-sided and were considered statistically significant if p<0.05. Analyses were carried out in December 2015 using Stata, version 14.0.
      The study was approved by scientific review and IRBs at Lancaster University and the Walter Reed Army Institute of Research.

      Results

      Chlamydia

      Between 2006 and 2012, a total of 37,149 chlamydia case patients were identified among U.S. Army women. Of these, 89% had high school education, 85% were in the lower enlisted rank, 80% were aged <25 years, 68% were single, 49% had at least 1 year of military service, 48% had home of record in the South, and 34% were African American. Among the 371,490 controls, 84% had high school education, 78% were of lower enlisted rank, 64% were single, 41% had at least 1 year of military service, 40% were from the South, and 21% were African American.
      The prevalence of BV was higher among chlamydia cases than their controls (21.4% vs 15.6%, p<0.001) (Table 1). For both chlamydia cases and controls, the highest BV prevalences occurred among women with senior enlisted rank, those with >3 years of service, those with “other” marital status, women with college or higher education, married personnel, and among African Americans.
      Table 1BV Prevalence Among Chlamydia and Gonorrhea Cases and Matched Controls Among U.S. Army Females
      FeatureChlamydiaGonorrhea
      CasesControlsCasesControls
      BV %n/NBV %n/NBV %n/NBV %n/N
      All participants21.47,942/37,14915.657,793/371,49034.71,730/4,98719.19,523/49,870
      Race/ethnicity
       White16.52,440/14,82712.223,623/193,29126.1297/1,13614.23,608/25,096
       African-American29.13,715/12,75326.220,326/77,71239.41,119/2,83831.83,681/11,571
       Hispanic20.0996/4,99014.97,732/51,94932.0168/52518.51,252/6,777
       Other
      Other: American Indian/Alaskan Native, Asian/Pacific Islander, and others.
      15.7623/3,96111.44,700/41,23627.1106/39113.6740/5,426
      Education level
       No high school17.424/13813.4167/1,24415.03/2019.733/167
       High school20.56,758/32,92914.946,727/312,69234.11,521/4,45618.47,602/41,330
       College or higher29.71,060/3,56420.310,160/50,05841.7183/43924.11,766/7,325
      Marital status
       Single16.64,211/25,37111.226,653/238,86528.2919/3,25713.84,181/30,369
       Married29.32,748/9,37322.326,398/118,43644.2605/1,37025.64,376/17,107
       Other
      Other: Divorced, widowed, and others.
      40.9976/2,38733.74,712/13,99357.1201/35240.6960/2,367
      Region of birth
      West (MT, WY, CT, NM, ID, UT, AZ, NV, WA, OR, CA, AK, and HI); Midwest (IL, IN, IA, KS, MI, MN, MO, OH, NE, ND, SD, and WI); Northeast (ME, NH, VT, MA, RI, CT, NY, NJ, and PA); South (FL, GA, NC, SC, VA, WV, MD, DC, DE, AL, KY, MS, TN, AR, LA, OK, and TX). BV, bacterial vaginosis.
       West17.61,233/7,00312.610,694/84,99729.1196/67315.21,680/11,031
       Midwest19.31,021/5,27913.87,995/57,71635.3211/59816.61,246/7,519
       Northeast22.5810/3,60515.66,427/41,16936.8164/44519.41,040/5,355
       South23.74,187/17,69017.826,608/149,20735.51,033/2,90622.04,468/20,343
      Military rank
       Junior enlisted17.75,586/31,57912.135,149/289,50230.21,239/4,10714.65,420/37,029
       Senior enlisted46.02,091/4,54435.318,884/53,42959.4458/77138.83,470/8,931
       Officers25.8265/1,02613.23,760/28,55930.333/10916.2633/3,910
      Years of military service
       ≤19.81,784/18,1485.48,383/154,24116.3339/2,0726.61,191/18,126
       2−323.72,364/9,95415.417,562/114,27937.8508/1,34217.22,611/15,203
       ≥441.93,794/9,04730.931,848/102,97056.2883/1,57234.65,721/16,541
      a Other: American Indian/Alaskan Native, Asian/Pacific Islander, and others.
      b Other: Divorced, widowed, and others.
      c West (MT, WY, CT, NM, ID, UT, AZ, NV, WA, OR, CA, AK, and HI); Midwest (IL, IN, IA, KS, MI, MN, MO, OH, NE, ND, SD, and WI); Northeast (ME, NH, VT, MA, RI, CT, NY, NJ, and PA); South (FL, GA, NC, SC, VA, WV, MD, DC, DE, AL, KY, MS, TN, AR, LA, OK, and TX).BV, bacterial vaginosis.
      After adjusting for covariates, BV was significantly associated with chlamydia infection (incidence rate ratio=1.51; p<0.001) (Table 2). These analyses also showed that the association between BV and chlamydia was higher in women with junior enlisted rank, women who had ≤2 years of military service, women with single marital status, and who were from the Northeast. Interestingly, the association between BV and chlamydia was higher among white women compared with African-American and Hispanic women.
      Table 2Crude and Adjusted Associations Between BV and Chlamydia and Gonorrhea Among U.S. Army Females
      FeatureChlamydiaGonorrhea
      IRR (95% CI)Adjusted
      Adjusted IRR for race/ethnicity, marital status, and military rank.
      IRR (95% CI)
      IRR (95% CI)Adjusted
      Adjusted IRR for race/ethnicity, marital status, and military rank.
      IRR (95% CI)
      All participants1.52 (1.47, 1.56)1.51 (1.47, 1.55)2.42 (2.26, 2.58)2.42 (2.27, 2.57)
      Race/ethnicity
       White1.46 (1.39, 1.54)1.43 (1.36, 1.50)2.28 (1.94, 2.68)2.31 (1.96, 2.71)
       African American1.22 (1.16, 1.29)1.24 (1.17, 1.31)1.56 (1.41, 1.73)1.58 (1.42, 1.75)
       Hispanic1.33 (1.20, 1.49)1.36 (1.22, 1.52)2.08 (1.53, 2.82)2.12 (1.55, 2.90)
       Other
      Other: American Indian/Alaskan Native, Asian/Pacific Islander, and others.
      1.33 (1.15, 1.53)1.36 (1.18, 1.57)2.65 (1.76, 3.99)2.68 (1.78, 4.03)
      Education level
       No high schoolUndefined
      Undefined IRR, zero or infinity.
      Undefined
      Undefined IRR, zero or infinity.
      Undefined
      Undefined IRR, zero or infinity.
      Undefined
      Undefined IRR, zero or infinity.
       High school1.44 (1.40, 1.49)1.50 (1.46, 1.55)2.32 (2.16, 2.49)2.44 (2.27, 2.62)
       College or higher1.68 (1.53, 1.84)1.44 (1.31, 1.59)2.20 (1.72, 2.81)1.90 (1.47, 2.46)
      Marital status
       Single1.63 (1.57, 1.69)1.59 (1.53, 1.65)2.71 (2.47, 2.97)2.66 (2.42, 2.91)
       Married1.46 (1.38, 1.54)1.44 (1.36, 1.51)2.24 (1.97, 2.54)2.23 (1.96, 2.54)
       Other
      Other: Divorced, widowed, and others.
      1.38 (1.18, 1.61)1.37 (1.17, 1.60)1.68 (1.18, 2.41)1.66 (1.15, 2.39)
      Region of birth
      West (MT, WY, CT, NM, ID, UT, AZ, NV, WA, OR, CA, AK, and HI); Midwest (IL, IN, IA, KS, MI, MN, MO, OH, NE, ND, SD, and WI); Northeast (ME, NH, VT, MA, RI, CT, NY, NJ, and PA); South (FL, GA, NC, SC, VA, WV, MD, DC, DE, AL, KY, MS, TN, AR, LA, OK, and TX). BV, bacterial vaginosis; IRR, incidence rate ratio.
       West1.43 (1.32, 1.56)1.42 (1.31, 1.55)2.55 (1.99, 3.26)2.59 (2.02, 3.32)
       Midwest1.51 (1.36, 1.68)1.49 (1.34, 1.66)2.90 (2.16, 3.90)2.85 (2.10, 3.87)
       Northeast1.60 (1.40, 1.83)1.52 (1.33, 1.75)2.48 (1.75, 3.51)2.41 (1.69, 3.43)
       South1.47 (1.41, 1.54)1.48 (1.42, 1.54)2.12 (1.93, 2.33)2.14 (1.95, 2.36)
      Military rank
       Junior enlisted2.20 (1.78, 2.71)2.15 (1.74, 2.66)2.37 (1.28, 4.37)2.40 (1.29, 4.46)
       Senior enlisted1.47 (1.43, 1.52)1.50 (1.45, 1.55)2.46 (2.28, 2.66)2.53 (2.34, 2.74)
       Officers1.56 (1.45, 1.67)1.54 (1.43, 1.65)2.22 (1.88, 2.63)2.19 (1.85, 2.60)
      Years of military service
       ≤11.81 (1.71, 1.92)1.82 (1.72, 1.93)2.74 (2.36, 3.18)2.74 (2.35, 3.19)
       2−31.71 (1.61, 1.81)1.72 (1.63, 1.83)2.95 (2.56, 3.38)2.95 (2.56, 3.40)
       ≥41.63 (1.56, 1.71)1.61 (1.53, 1.69)2.42 (2.16, 2.70)2.38 (2.13, 2.68)
      a Adjusted IRR for race/ethnicity, marital status, and military rank.
      b Other: American Indian/Alaskan Native, Asian/Pacific Islander, and others.
      c Undefined IRR, zero or infinity.
      d Other: Divorced, widowed, and others.
      e West (MT, WY, CT, NM, ID, UT, AZ, NV, WA, OR, CA, AK, and HI); Midwest (IL, IN, IA, KS, MI, MN, MO, OH, NE, ND, SD, and WI); Northeast (ME, NH, VT, MA, RI, CT, NY, NJ, and PA); South (FL, GA, NC, SC, VA, WV, MD, DC, DE, AL, KY, MS, TN, AR, LA, OK, and TX).BV, bacterial vaginosis; IRR, incidence rate ratio.
      When BV was treated as a continuous variable, for every additional one episode of BV, the risk of chlamydia infection increased by 13% (95% CI=12%, 14%) compared with women without BV. A similar estimate was found after controlling for race/ethnicity, marital status, and military rank (data not shown). When BV was treated as a categorical predictor, a dose−response relationship with chlamydia infection was found (Figure 1). Women with one episode of BV had 1.45 (95% CI=1.40, 1.50) times more risk of acquiring chlamydia infection compared with women without BV. Additionally, for women with two, three, four, five, and six or more episodes of BV, the risk of acquiring chlamydia compared with women without BV was 1.55 (95% CI=1.47, 1.64), 1.74 (95% CI=1.61, 1.88), 1.46 (95% CI=1.29, 1.65), 1.95 (95% CI=1.68, 2.26), and 2.07 (95% CI=1.83, 2.33), times higher, respectively.
      Figure 1.
      Figure 1Associations for chlamydia infection by the number of episodes of bacterial vaginosis among U.S. Army females.
      The analysis did not detect an additive effect modification between BV and chlamydia by race categorized into two groups (African-American race and other race/ethnic groups [white/Hispanic/other]; synergy=1.02, 95% CI=0.88, 1.90; RERI=0.04, 95% CI=−0.24, 0.36).

      Gonorrhea

      During the study period, a total of 4,987 gonorrhea case patients were identified (Table 1). Of these, 89% had high school education, 82% were lower enlisted rank, 76% were aged <25 years, 65% were single, 58% were from the South, 57% were African American, and 41% had at least 1 year of military service. Among the 49,870 controls, 83% had high school education, 74% were lower enlisted rank, 61% were single, 41% were from the South, 36% had at least 1 year of military service, and 23% were African American.
      The prevalence of BV was higher among gonorrhea cases than their controls (34.7% vs 19.1%, p<0.001) (Table 1). Similar to the chlamydia results, the highest BV prevalences among gonorrhea cases and controls occurred among senior enlisted personnel, among women with ≥4 years of service, African-American women, those with other marital status, and among women with college or higher education.
      In a regression analysis, BV was significantly associated with gonorrhea (incidence rate ratio=2.42; p<0.001). After controlling for race, marital status, and military rank, the association between BV and gonorrhea was higher in women with the following characteristics: those with <4 years of military service, those from the Midwest, single women, and those of other race/ethnic groups.
      Analyses also revealed that for every additional episode of BV, the risk of gonorrhea infection increases 26% (95% CI=23%, 28%, p<0.001) compared with women without BV. This estimate was similar after controlling for race/ethnicity, marital status, and military rank (data not shown). When BV was analyzed as a categorical predictor, the results showed a linear association between the number of episodes of BV and acquisition of gonorrhea infection (Figure 2). According to this dose−response analysis, women with one episode of BV had 1.98 (95% CI=1.82, 2.15) times more risk of acquiring gonorrhea compared with women without BV. Additionally, compared with women without BV, the risk of acquiring gonorrhea among women with two, three, four, five, and six or more episodes was 2.71 (95% CI=2.41, 3.04), 3.22 (95% CI=2.74, 3.79), 3.62 (95% CI=2.87, 4.55), 4.12 (95% CI=3.14, 5.40), and 4.62 (95% CI=3.73, 5.73), respectively.
      Figure 2.
      Figure 2Associations for gonorrhea infection by the number of episodes of bacterial vaginosis among U.S. Army females.
      Analyses also found that using an additive scale, race/ethnicity was a positive effect modifier for the relationship between BV and gonorrhea (synergy=1.29, 95% CI=1.05, 1.58; RERI=1.80, 95% CI=0.25, 3.34). This synergistic relationship indicates that the joint exposure effect of BV and African-American race on gonorrhea was larger than the sum of the effect of African-American race on gonorrhea risk and of BV on gonorrhea risk.

      Discussion

      Antecedent BV was associated with subsequent chlamydia and gonorrhea infection among women in the U.S. Army. This represents the first large study to provide objective evidence of the role of the most common cause of vaginal discharge, BV, on these two STIs. This association was previously reported only among high-risk women in civilian populations.
      • Brotman R.M.
      • Shardell M.D.
      • Gajer P.
      • et al.
      Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.
      • Wiesenfeld H.C.
      • Hillier S.L.
      • Krohn M.A.
      • Landers D.V.
      • Sweet R.L.
      Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.
      • Gallo M.F.
      • Macaluso M.
      • Warner L.
      • et al.
      Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links.
      • Brotman R.M.
      • Klebanoff M.A.
      • Nansel T.R.
      • et al.
      Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.
      Although it is difficult to estimate the exact prevalence of BV, as many women are asymptomatic, limited data on this vaginal condition indicates that among women entering military service in the U.S. Marine Corps during 1999−2000, a high prevalence was found among African-American (32%) and Hispanic women (30%).
      • Fethers K.A.
      • Fairley C.K.
      • Hocking J.S.
      • Gurrin L.C.
      • Bradshaw C.S.
      Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.
      This finding is in agreement with that observed in this study, in which African-American and Hispanic women had the highest BV prevalences.
      The prevalence of BV was two and three times higher among African-American women with chlamydia or gonorrhea compared with white women. This disparity, which has been reported in civilian studies,
      • Koumans E.H.
      • Markowitz L.E.
      • Hogan V.
      CDC BV Working Group
      Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.
      • Wiesenfeld H.C.
      • Hillier S.L.
      • Krohn M.A.
      • Landers D.V.
      • Sweet R.L.
      Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.
      cannot be explained by differences in sexual activity or sociodemographic characteristics.
      • Royce R.A.
      • Jackson T.P.
      • Thorp Jr, J.M.
      • et al.
      Race/ethnicity, vaginal flora patterns, and pH during pregnancy.
      It is possible that it is associated with lifestyle factors that are more common among African-American women, such as vaginal douching. Vaginal douching, which causes a disequilibrium in the vaginal microflora, induces inflammation through either physical or chemical irritation, and therefore predisposes women to BV.
      • Brotman R.M.
      • Klebanoff M.A.
      • Nansel T.R.
      • et al.
      A longitudinal study of vaginal douching and bacterial vaginosis: a marginal structural modeling analysis.
      On the other hand, it is hypothesized that differences in the composition of bacterial vaginal flora between whites and African Americans might explain this disparity,
      • Hickey R.J.
      • Zhou X.
      • Pierson J.D.
      • Ravel J.
      • Forney L.J.
      Understanding vaginal microbiome complexity from an ecological perspective.
      but there is no direct evidence of such a complex relationship.
      This study found that women with BV were 1.5 and 2.4 times more likely to have a subsequent chlamydia or gonorrhea diagnosis when compared with their aged-matched controls, respectively. These estimates were smaller for chlamydia, and higher for gonorrhea, when compared with estimates from a large cohort study among 3,620 non-pregnant women aged 15−44 years (hazard ratio for chlamydia=1.9; hazard ratio for gonorrhea=1.8).
      • Brotman R.M.
      • Klebanoff M.A.
      • Nansel T.R.
      • et al.
      Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.
      These findings are consistent with previous research suggesting that BV facilitates the acquisition of these STIs.
      This study also documents that among Hispanic women, the relationship of BV with chlamydia or gonorrhea infection was higher when compared with African-American women. Data on the dynamics of STI transmission, including gonorrhea, among Hispanic women is limited in the military literature, despite the fact that this minority group has increased its representation in the U.S. military from 4% in 1981 to 13% in 2013.
      • Holder K.
      Post 9/11 women veterans. Proceedings of the Annual Meeting of the Population Association of America; Apr 15−17;2010.
      Further studies are warranted in the military to determine what individual, social, or biological factors contribute to the risk of STIs among Hispanic women.
      Analyses revealed that among single and enlisted women, the association of BV with chlamydia or gonorrhea was stronger compared with those who were married or officers. Studies of active duty service women, who are mostly single and young, report that they engage in high-risk sexual behaviors (e.g., multiple sexual partners, low condom use, and sex while under the influence of drugs or alcohol).
      Armed Forces Health Surveillance Center
      Sexually transmitted infections, active component, U.S. Armed Forces, 2000−2012.
      • Stahlman S.
      • Javanbakht M.
      • Cochran S.
      • et al.
      Self-reported STIs and sexual risk behaviors in the U.S. military: how gender influences risk.
      Additionally, among young female recruits (aged 17−21 years), BV has been associated with having more than one sexual partner in the past 3 months.
      • Fethers K.A.
      • Fairley C.K.
      • Hocking J.S.
      • Gurrin L.C.
      • Bradshaw C.S.
      Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.
      Considering these findings, it is valid to assume that high-risk sexual behaviors might explain the difference between single and married women. On the other hand, in the U.S. Army, enlisted personnel are predominantly young and unmarried. In this enlisted population, 71% of women were young (aged <25 years) and unmarried. Consequently, this high percentage may explain, in part, the high association of BV with chlamydia and gonorrhea among the enlisted ranks.
      An important finding from this study was that for every one additional episode of BV, the risk of acquiring chlamydia and gonorrhea infection increased by 13% and 26%, respectively. This increased risk was independent of other covariates. To the best of the authors’ knowledge, there is no evidence in the literature on the risk of STIs by the number of episodes of BV. Although the basis for this increased risk is not known, this study presents evidence for the cumulative effect of BV on the risk for these infections.
      This study also found a dose−response relationship between antecedent BV and subsequent chlamydia and gonorrhea diagnosis. The shape of this relationship was monotonic, which indicates that the risk of these infections increases with the number of episodes of BV. For simplicity, the shape of the trend was analyzed descriptively, and not using advanced statistical models, such as splines.
      • Steenland K.
      • Deddens J.A.
      A practical guide to dose-response analyses and risk assessment in occupational epidemiology.
      This dose−response relationship supports the role of BV in the risk of STI acquisition. In addition to the observed strength of the association, an important component for disease causality, the presence of a dose−response relationship has public health implications in terms of disease prevention because it provides clues to the biology underlying bacterial−STI relationship.
      Effect modification analyses found a synergistic effect between BV and African-American race for gonorrhea, but not for chlamydia. Although the mechanisms of this effect remain unclear, biological factors, in addition to individual behavioral and social factors, may explain racial disparities in STI acquisition.
      • Royce R.A.
      • Jackson T.P.
      • Thorp Jr, J.M.
      • et al.
      Race/ethnicity, vaginal flora patterns, and pH during pregnancy.
      • Brotman R.M.
      • Klebanoff M.A.
      • Nansel T.R.
      • et al.
      A longitudinal study of vaginal douching and bacterial vaginosis: a marginal structural modeling analysis.
      • Hickey R.J.
      • Zhou X.
      • Pierson J.D.
      • Ravel J.
      • Forney L.J.
      Understanding vaginal microbiome complexity from an ecological perspective.
      However, the nature of STIs among African Americans is complex, multifactorial in nature, and requires further individual and social network−level behavioral research. This is the first study that suggests that African-American race modifies the association between BV and gonorrhea infection.
      Taken together, this study provides additional evidence of a probable causal link between BV and chlamydia and gonorrhea infection. These conclusions are supported by the strength of the associations, the temporal sequence of the associations, the consistency of findings with previous studies, and a dose−response relationship.

      Limitations

      This study has some limitations. It is likely that the reported number of women with BV was affected by the limitations of use of ICD-9 codes as indicators of BV. Therefore, it is probable that some women with BV were misclassified or had other conditions that also cause an inflammation or infection of the vagina, such as candidiasis or noninfectious vaginitis. It was not possible to analyze behavioral risk data, given that this information is not collected in DMSS. Further research should study the influence of behavioral factors (e.g., sexual practices, douching, use of condoms, and frequency of vaginal sex) on the association of BV with chlamydia and gonorrhea among military women.

      Conclusions

      Among women in the U.S. Army, antecedent BV is associated with an increased risk of subsequent chlamydia and gonorrhea infection. This finding is consistent with those observed amongst civilian populations where BV has been reported to represent a strong risk factor for both bacterial STIs. The dose−response relationship between the number of episodes of BV and chlamydia or gonorrhea infection highlights the importance of BV as a clinical risk factor, which can be considered “hypothesis generating” for further research in the field of STIs. The study also provides important evidence-based public health findings for U.S. military authorities to develop prevention strategies such as sexual risk reduction for female service members with BV in order to reduce the acquisition of STIs. These results strengthen the literature that BV constitutes a predisposing condition that increases the risk of both chlamydia and gonorrhea infections.

      Acknowledgments

      The authors would like to thank Dr. Angelia Cost, a senior managing epidemiologist at the Armed Forces Health Surveillance Branch, for Defense Medical Surveillance System database extraction and epidemiologic support for this study, and to Mr. Sebastian-Santiago for technical assistance.
      This study was funded by the U.S. Armed Forces Health Surveillance Branch and its Global Emerging Infectious Surveillance section.
      The views expressed herein are those of the authors and do not reflect the official policy or position of the Department of the Army, Department of Defense, the U.S. Government, or any listed organization. Some authors are employees of the U.S. government. This work was prepared as part of their official duties and, as such, there is no copyright to be transferred. This report was approved for publication by the U.S. Army Public Health Command.
      Preliminary results from this study were presented at the 29th European Conference on Sexually Transmitted Infections, poster #168, Barcelona, Spain, September 24−26, 2015.
      No financial disclosures were reported by the authors of this paper.

      References

        • Koumans E.H.
        • Sternberg M.
        • Bruce C.
        • et al.
        The prevalence of bacterial vaginosis in the United States, 2001-2004; associations with symptoms, sexual behaviors, and reproductive health.
        Sex Transm Dis. 2007; 34: 864-869https://doi.org/10.1097/OLQ.0b013e318074e565
        • Kenyon C.
        • Colebunders R.
        • Crucitti T.
        The global epidemiology of bacterial vaginosis: a systematic review.
        Am J Obstet Gynecol. 2013; 209: 505-523https://doi.org/10.1016/j.ajog.2013.05.006
        • Koumans E.H.
        • Markowitz L.E.
        • Hogan V.
        • CDC BV Working Group
        Indications for therapy and treatment recommendations for bacterial vaginosis in nonpregnant and pregnant women: a synthesis of data.
        Clin Infect Dis. 2002; 35: S152-S172
        • Fethers K.A.
        • Fairley C.K.
        • Hocking J.S.
        • Gurrin L.C.
        • Bradshaw C.S.
        Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.
        Clin Infect Dis. 2008; 47: 1426-1435https://doi.org/10.1086/592974
        • Yen S.
        • Shafer M.A.
        • Moncada J.
        • et al.
        Bacterial vaginosis in sexually experienced and non-sexually experienced young women entering the military.
        Obstet Gynecol. 2003; 102: 927-933https://doi.org/10.1016/S0029-7844(03)00858-5
        • Smart S.
        • Singal A.
        • Mindel A.
        Social and sexual risk factors for bacterial vaginosis.
        Sex Transm Infect. 2004; 80: 58-62https://doi.org/10.1136/sti.2003.004978
        • Verstraelen H.
        • Verhelst R.
        • Vaneechoutte M.
        • Temmerman M.
        The epidemiology of bacterial vaginosis in relation to sexual behaviour.
        BMC Infect Dis. 2010; 10: 81https://doi.org/10.1186/1471-2334-10-81
        • Fethers K.A.
        • Fairley C.K.
        • Morton A.
        • et al.
        Early sexual experiences and risk factors for bacterial vaginosis.
        J Infect Dis. 2009; 200: 1662-1670https://doi.org/10.1086/648092
        • Leopold S.
        Heretofore undescribed organism isolated from the genitourinary system.
        U.S. Armed Forces Med. 1953; 4: 263-266
        • Gardner H.L.
        • Dukes C.D.
        Haemophilus vaginalis vaginitis: a newly defined specific infection previously classified non-specific vaginitis.
        Am J Obstet Gynecol. 1955; 69: 962-976https://doi.org/10.1016/0002-9378(55)90095-8
        • Turovskiy Y.
        • Noll K.S.
        • Chikindas M.L.
        The aetiology of bacterial vaginosis.
        J Appl Microbiol. 2011; 110: 1105-1128https://doi.org/10.1111/j.1365-2672.2011.04977.x
        • Leppäluoto P.A.
        Autopsy of bacterial vaginosis: a physiological entity rather than a contagious disease.
        Acta Obstet Gynecol Scand. 2008; 87: 578-579https://doi.org/10.1080/00016340802031049
        • Mirmonsef P.
        • Krass L.
        • Landay A.
        • Spear G.T.
        The role of bacterial vaginosis and trichomonas in HIV transmission across the female genital tract.
        Curr HIV Res. 2012; 10: 202-210https://doi.org/10.2174/157016212800618165
        • Nagot N.
        • Quedraogo A.
        • Defer M.C.
        • et al.
        Association between bacterial vaginosis and Herpes simplex virus type-2 infection: implications for HIV acquisition studies.
        Sex Transm Infect. 2007; 83: 365-368https://doi.org/10.1136/sti.2007.024794
        • Brotman R.M.
        • Shardell M.D.
        • Gajer P.
        • et al.
        Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection.
        J Infect Dis. 2014; 210: 1723-1733https://doi.org/10.1093/infdis/jiu330
        • Wiesenfeld H.C.
        • Hillier S.L.
        • Krohn M.A.
        • Landers D.V.
        • Sweet R.L.
        Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection.
        Clin Infect Dis. 2003; 36: 663-668https://doi.org/10.1086/367658
        • Gallo M.F.
        • Macaluso M.
        • Warner L.
        • et al.
        Bacterial vaginosis, gonorrhea, and chlamydial infection among women attending a sexually transmitted disease clinic: a longitudinal analysis of possible causal links.
        Ann Epidemiol. 2012; 22: 213-220https://doi.org/10.1016/j.annepidem.2011.11.005
        • Brotman R.M.
        • Klebanoff M.A.
        • Nansel T.R.
        • et al.
        Bacterial vaginosis assessed by gram stain and diminished colonization resistance to incident gonococcal, chlamydial, and trichomonal genital infection.
        J Infect Dis. 2010; 202: 1907-1915https://doi.org/10.1086/657320
        • Allsworth J.E.
        • Peipert J.F.
        Severity of bacterial vaginosis and the risk of sexually transmitted infection.
        Am J Obstet Gynecol. 2011; 205: 113https://doi.org/10.1016/j.ajog.2011.02.060
        • Armed Forces Health Surveillance Center
        Sexually transmitted infections, active component, U.S. Armed Forces, 2000−2012.
        MSMR. 2013; 20: 5-10
        • Rubertone M.V.
        • Brundage J.F.
        The Defense Medical Surveillance System and the Department of Defense serum repository: glimpses of the future of public health surveillance.
        Am J Public Health. 2002; 92: 1900-1904https://doi.org/10.2105/AJPH.92.12.1900
        • Bautista C.T.
        • Sateren W.B.
        • Sanchez J.L.
        • et al.
        HIV incidence trends among white and African-American active duty United States Army personnel (1986−2003).
        J Acquir Immune Defic Syndr. 2006; 43: 351-355https://doi.org/10.1097/01.qai.0000243051.35204.d0
        • Bautista C.T.
        • Singer D.E.
        • O’Connell R.J.
        • et al.
        Herpes simplex virus type 2 and HIV infection among U.S. military personnel: implications for health prevention programmes.
        Int J STD AIDS. 2009; 20: 634-637https://doi.org/10.1258/ijsa.2008.008413
        • Richardson D.
        An incidence density sampling program for nested case-control analyses.
        Occup Environ Med. 2004; 61: e59https://doi.org/10.1136/oem.2004.014472
      1. Rothman K.J. Greenland S. Lash T.L. Modern Epidemiology. Lippincott Williams & Wilkins, Philadelphia, PA2008
        • Eschenbach D.A.
        Bacterial vaginosis: resistance, recurrence, and/or reinfection?.
        Clin Infect Dis. 2007; 44: 220-221https://doi.org/10.1086/509584
        • Royce R.A.
        • Jackson T.P.
        • Thorp Jr, J.M.
        • et al.
        Race/ethnicity, vaginal flora patterns, and pH during pregnancy.
        Sex Transm Dis. 1999; 26: 96-102https://doi.org/10.1097/00007435-199902000-00007
        • Brotman R.M.
        • Klebanoff M.A.
        • Nansel T.R.
        • et al.
        A longitudinal study of vaginal douching and bacterial vaginosis: a marginal structural modeling analysis.
        Am J Epidemiol. 2008; 168: 188-196https://doi.org/10.1093/aje/kwn103
        • Hickey R.J.
        • Zhou X.
        • Pierson J.D.
        • Ravel J.
        • Forney L.J.
        Understanding vaginal microbiome complexity from an ecological perspective.
        Transl Res. 2012; 160: 267-282https://doi.org/10.1016/j.trsl.2012.02.008
        • Holder K.
        Post 9/11 women veterans. Proceedings of the Annual Meeting of the Population Association of America; Apr 15−17;2010.
        Housing and Household Economic Statistics Division, U.S. Census Bureau, Dallas, TX2010
        • Stahlman S.
        • Javanbakht M.
        • Cochran S.
        • et al.
        Self-reported STIs and sexual risk behaviors in the U.S. military: how gender influences risk.
        Sex Transm Dis. 2014; 41: 359-364https://doi.org/10.1097/OLQ.0000000000000133
        • Steenland K.
        • Deddens J.A.
        A practical guide to dose-response analyses and risk assessment in occupational epidemiology.
        Epidemiology. 2004; 15: 63-70https://doi.org/10.1097/01.ede.0000100287.45004.e7